title: BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era.
authors.affiliation: a 2nd Department of Internal Medicine, Propaedeutic , Hematology Unit, School of Medicine, National and Kapodistrian University of Athens, "Attikon" University General Hospital , Haidari , Greece ;
authors.forename: Sotirios G
authors.initials: SG
authors.lastname: Papageorgiou
authors.affiliation: b Department of Biochemistry and Molecular Biology , University of Athens , Athens , Greece ;
authors.forename: Christos K
authors.initials: CK
authors.lastname: Kontos
authors.affiliation: c 2nd Department of Pathology, School of Medicine , National and Kapodistrian University of Athens, "Attikon" University Hospital , Haidari , Greece.
authors.forename: Periklis G
authors.initials: PG
authors.lastname: Foukas
authors.affiliation: c 2nd Department of Pathology, School of Medicine , National and Kapodistrian University of Athens, "Attikon" University Hospital , Haidari , Greece.
authors.forename: Eleni
authors.initials: E
authors.lastname: Panopoulou
authors.affiliation: a 2nd Department of Internal Medicine, Propaedeutic , Hematology Unit, School of Medicine, National and Kapodistrian University of Athens, "Attikon" University General Hospital , Haidari , Greece ;
authors.forename: Diamantina
authors.initials: D
authors.lastname: Vasilatou
authors.affiliation: b Department of Biochemistry and Molecular Biology , University of Athens , Athens , Greece ;
authors.forename: Stamatia-Maria
authors.initials: SM
authors.lastname: Rapti
authors.affiliation: a 2nd Department of Internal Medicine, Propaedeutic , Hematology Unit, School of Medicine, National and Kapodistrian University of Athens, "Attikon" University General Hospital , Haidari , Greece ;
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Gkontopoulos
authors.affiliation: a 2nd Department of Internal Medicine, Propaedeutic , Hematology Unit, School of Medicine, National and Kapodistrian University of Athens, "Attikon" University General Hospital , Haidari , Greece ;
authors.forename: Efthimia
authors.initials: E
authors.lastname: Bazani
authors.affiliation: c 2nd Department of Pathology, School of Medicine , National and Kapodistrian University of Athens, "Attikon" University Hospital , Haidari , Greece.
authors.forename: Ioannis G
authors.initials: IG
authors.lastname: Panayiotides
authors.affiliation: a 2nd Department of Internal Medicine, Propaedeutic , Hematology Unit, School of Medicine, National and Kapodistrian University of Athens, "Attikon" University General Hospital , Haidari , Greece ;
authors.forename: George
authors.initials: G
authors.lastname: Dimitriadis
authors.affiliation: b Department of Biochemistry and Molecular Biology , University of Athens , Athens , Greece ;
authors.forename: Andreas
authors.initials: A
authors.lastname: Scorilas
authors.affiliation: a 2nd Department of Internal Medicine, Propaedeutic , Hematology Unit, School of Medicine, National and Kapodistrian University of Athens, "Attikon" University General Hospital , Haidari , Greece ;
authors.forename: Vasiliki
authors.initials: V
authors.lastname: Pappa
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D054316:Biomarkers, Pharmacological / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic; D018922:HL-60 Cells; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality; D009124:Muscle Proteins / Q000235:genetics* / Q000378:metabolism; D011379:Prognosis; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics* / Q000378:metabolism; D000069283:Rituximab / Q000008:administration & dosage / Q000627:therapeutic use*; D016019:Survival Analysis; D016896:Treatment Outcome; D015854:Up-Regulation / Q000235:genetics
chemical_list: C430100:BCL2L12 protein, human; D054316:Biomarkers, Pharmacological; D014408:Biomarkers, Tumor; D009124:Muscle Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D000069283:Rituximab